用酸治疗发症患者的潜在管功能障碍
Fumi Sawamura1, Jun Natsume2, Yuji Ito3
1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Epilepsy research
|June 12, 2025
概括
患者的酸 (VPA) 治疗可能导致潜在的管功能障碍 (RTD),尿液标志物升高表明. 这种功能障碍与肉素缺乏有关,强调了医生意识的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瓦尔酸 (VPA) 与Fanconi综合征和潜在的肉素缺乏症有关.
- 潜伏性管功能障碍 (RTD) 已在使用VPA的患者中观察到.
研究的目的:
- 评估在接受VPA治疗和不接受VPA治疗的患者中的潜在RTD.
- 检查尿液RTD标记物及其与临床变量之间的相关性.
主要方法:
- 在147名儿童发作患者的尿液中评估了N-乙-β-D-葡萄糖胺酶/肌素 (NAG/Cr) 和β2-微球蛋白/肌素 (BMG/Cr).
- 在VPA治疗 (n=90) 和非VPA治疗 (n=57) 组之间比较了RTD标志物.
- 在VPA组中对RTD标志物和临床变量进行了相关性和回归分析.
主要成果:
- 与非VPA组相比,在VPA组中观察到明显更高的NAG/Cr水平.
- 接受VPA治疗的94%的患者显示NAG/Cr水平高或边界水平.
- 在VPA组中的NAG/Cr与自由卡尼丁 (FC),VPA剂量和治疗持续时间相关;BMG/Cr与抗发作药物的数量相关.
结论:
- 隐性RTD在接受VPA治疗的患者中普遍存在.
- 高水平的RTD标志物,特别是NAG/Cr,与肉素缺乏有关.
- 临床医生应对接受VPA的患者进行潜在RTD监测.
更多相关视频
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
2.8K
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.7K
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
271
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
271
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
343
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
343
01:20Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
01:24Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
01:22Drug Elimination by Renal Route: Tubular Reabsorption
3.3K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.3K
01:17Antiepileptic Drugs: Calcium Channel Blockers
343
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
343